Zoetis Inc. (NYSE:ZTS) is one of the best drug stocks to buy right now. Zoetis Inc. (NYSE:ZTS) announced on September 12 the adoption of a positive opinion by the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) regarding recommending the granting of marketing authorization for Portela (relfovetmab). Is Zoetis a Unique Dividend Play in the Pharma Space for 2025? Portela is a new monoclonal antibody (mAb) therapy intended to alleviate pain associated with osteoarth ...